Fate Therapeutics
Founded 2007 · CIK 0001434316 · Biotech · Public
iPSC-derived natural killer and T cell therapeutics manufactured from induced pluripotent stem cells
fatetherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $236M
- 9 Form D · Jul 2020
- 75 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 17 granted · 23 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2009201120132015201720192021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $30,488,360 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $9,244,679 | |
| Private capital raised | Form D · SEC | $20,000,000 | |
| Private capital raised | Form D · SEC | $8,000,000 | |
| Private capital raised | Form D · SEC | $10,290,000 | |
| Private capital raised | Form D · SEC | $56,749,988 | |
| Private capital raised | Form D · SEC | $50,000,024 | |
| Private capital raised | Form D · SEC | $49,999,989 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2395 | Translate Bio | — | $98M |
| 2396 | NeuvaRx, LLC | — | — |
| 2397 | Antiva Biosciences | — | $81M |
| 2398 | Fate Therapeutics | — | $236M |
| 2399 | COLORADO RESEARCH PARTNERS, LLC | — | — |
| 2400 | Halda Therapeutics | — | $198M |
| 2401 | MCM6 THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- STEWART ABBOTExecutive Officer
- Shefali AgarwalDirector
- Timothy CoughlinDirector
- TIMOTHY COUGHLINDirector
- Mark EnyedyDirector
- MARK ENYEDYDirector
- Robert EpsteinDirector
- ROBERT EPSTEINDirector
- PAUL GraysonDirector · Executive Officer
- Robert HershbergDirector
- Karin JoossDirector
- Michael LeeDirector
- John MendleinDirector · Executive Officer
- JOHN MENDLEINDirector
- Amir NashatDirector
- AMIR NASHATDirector
- Robert NelsenDirector
- William RastetterDirector · Executive Officer
- WILLIAM RASTETTERDirector
- Bryan RobertsDirector
- Daniel ShoemakerExecutive Officer
- DANIEL SHOEMAKERExecutive Officer
- CHRIS STORGARDExecutive Officer
- Cindy TahlExecutive Officer
- CINDY TAHLExecutive Officer
- Carl WeissmanDirector
- Christian WeyerDirector · Executive Officer
- J. Scott WolchkoDirector · Executive Officer
- Scott WolchkoExecutive Officer
- J. SCOTT WOLCHKODirector · Executive Officer
Patents
- Genomic Engineering Of Pluripotent Cellsgranted
- Reprogramming Methods And Cell Culture Platformsgranted
- Methods And Compositions For Inducing Hematopoietic Cell Differentiationapplication
- Adjustable Grip Support For Handheld Pipetteapplication
- Vial Rackgranted
- Methods And Compositions For Inducing Hematopoietic Cell Differentiationapplication
- Cell Culture Platform For Single Cell Sorting And Enhanced Reprogramming Of Ipscsapplication
- Methods And Compositions For Inducing Hematopoietic Cell Differentiationapplication
- Enhancing Effector Cell Durability And Efficacy In Adoptive Cell Therapiesapplication
- Stealth Strategy Engaging Immune Recognition Pathways For Use In Allogeneic Cell Therapiesapplication
- Combining Ipsc Derived Effector Cell Types For Immunotherapy Useapplication
- IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLSgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.